Your browser doesn't support javascript.
loading
The use of high-throughput sequencing to investigate an outbreak of glycopeptide-resistant Enterococcus faecium with a novel quinupristin-dalfopristin resistance mechanism.
Shaw, Timothy D; Fairley, D J; Schneiders, T; Pathiraja, M; Hill, R L R; Werner, G; Elborn, J S; McMullan, R.
Affiliation
  • Shaw TD; Centre for Experimental Medicine, Queen's University Belfast, Belfast, Northern Ireland, UK. t.shaw@qub.ac.uk.
  • Fairley DJ; Department of Medical Microbiology, Kelvin Laboratory, Royal Victoria Hospital, Belfast, Northern Ireland, UK. t.shaw@qub.ac.uk.
  • Schneiders T; Centre for Experimental Medicine, Queen's University Belfast, Belfast, Northern Ireland, UK.
  • Pathiraja M; Department of Medical Microbiology, Kelvin Laboratory, Royal Victoria Hospital, Belfast, Northern Ireland, UK.
  • Hill RLR; Division of Infection and Pathway Medicine, University of Edinburgh Medical School, Edinburgh, Scotland, UK.
  • Werner G; Department of Medical Microbiology, Kelvin Laboratory, Royal Victoria Hospital, Belfast, Northern Ireland, UK.
  • Elborn JS; Antimicrobial Resistance & Healthcare-Associated Infection, Public Health England, London, UK.
  • McMullan R; National Reference Centre for Staphylococci and Enterococci, Robert Koch-Institute, Wernigerode Branch, Berlin, Germany.
Eur J Clin Microbiol Infect Dis ; 37(5): 959-967, 2018 May.
Article in En | MEDLINE | ID: mdl-29478197

Full text: 1 Database: MEDLINE Main subject: Glycopeptides / Disease Outbreaks / Virginiamycin / Gram-Positive Bacterial Infections / Enterococcus faecium / Drug Resistance, Bacterial / Anti-Bacterial Agents Limits: Humans Language: En Year: 2018 Type: Article

Full text: 1 Database: MEDLINE Main subject: Glycopeptides / Disease Outbreaks / Virginiamycin / Gram-Positive Bacterial Infections / Enterococcus faecium / Drug Resistance, Bacterial / Anti-Bacterial Agents Limits: Humans Language: En Year: 2018 Type: Article